https://www.selleckchem.com/pr....oducts/qnz-evp4593.h
All intended priority populations were reached, notably those who had never tested before 35% in Phase 1 and 12% in Phase 2. Over half of follow-up survey respondents reported testing sooner. Respondents reported liking the HIVST because it did not require a visit to a clinic (84%) and preferred a HIVST to testing in a clinic (92%). CONCLUSIONS Through two phases of implementation, this innovative partnership was able to reach and offer HIVSTs to priority populations across NYC. This program supports the feasibility of distributing
Like
Comment
Share
